JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1759, Issue 1-2, 2006, Pages 60-68

  Goto, Yuya ^a   Hayashi, Reiko ^a   Muramatsu, Tomoki ^a   Ogawa, Hitomi ^a   Eguchi, Ikumi ^a   Oshida, Yasuhiro ^a   Ohtani, Kiyoshi ^b   Yoshida, Kenichi ^a  

^a MEIJI UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

c Myc; E2F1; JPO1 CDCA7; Promoter; Transcriptional regulation

Indexed keywords

CYSTEINE; MESSENGER RNA; MYC PROTEIN; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; TRANSCRIPTION FACTOR E2F6; CDCA7 PROTEIN, HUMAN; E2F1 PROTEIN, HUMAN; E2F2 PROTEIN, HUMAN; E2F4 PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ADENOVIRUS; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BINDING SITE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HELA CELL; METABOLISM; MOUSE; PHYSIOLOGY; REGULATORY SEQUENCE;

MAMMALIA;

ANIMALS; BINDING SITES; E2F1 TRANSCRIPTION FACTOR; E2F2 TRANSCRIPTION FACTOR; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; MICE; NUCLEAR PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 33746223202     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2006.02.004     Document Type: Article

References (53)

1. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12 (1998) 2245-2262
2. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9 (1998) 585-593
3. Frolov M.V., and Dyson N.J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117 (2004) 2173-2181
4. Stevens C., and La Thangue N.B. E2F and cell cycle control: a double-edged sword. Arch. Biochem. Biophys. 412 (2003) 157-169
5. Attwooll C., Lazzerini Denchi E., and Helin K. The E2F family: specific functions and overlapping interests. EMBO J. 23 (2004) 4709-4716
6. Cam H., and Dynlacht B.D. Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3 (2003) 311-316
7. Dimova D.K., and Dyson N.J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24 (2005) 2810-2826
8. Nevins J.R. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10 (2001) 699-703
9. Adams P.D., and Kaelin W.G.J. Transcriptional control by E2F. Semin. Cancer Biol. 6 (1995) 99-108
10. Yoshida K., and Inoue I. Regulation of Geminin and Cdt1 expression by E2F transcription factors. Oncogene 23 (2004) 3802-3812
11. Yoshida K., and Inoue I. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor. Oncogene 23 (2004) 6250-6260
12. Walker M.G. Drug target discovery by gene expression analysis: cell cycle genes. Curr. Cancer Drug Targets 1 (2001) 73-83
13. Osborne M.A., Schlenstedt G., Jinks T., and Silver P.A. Nuf2, a spindle pole body-associated protein required for nuclear division in yeast. J. Cell Biol. 125 (1994) 853-866
14. DeLuca J.G., Moree B., Hickey J.M., Kilmartin J.V., and Salmon E.D. hNuf2 inhibition blocks stable kinetochore-microtubule attachment and induces mitotic cell death in HeLa cells. J. Cell Biol. 159 (2002) 549-555
15. Ayad N.G., Rankin S., Murakami M., Jebanathirajah J., Gygi S., and Kirschner M.W. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell 113 (2003) 101-113
16. Rankin S., Ayad N.G., and Kirschner M.W. Sororin, a substrate of the anaphase-promoting complex, is required for sister chromatid cohesion in vertebrates. Mol. Cell 18 (2005) 185-200
17. Gassmann R., Carvalho A., Henzing A.J., Ruchaud S., Hudson D.F., Honda R., Nigg E.A., Gerloff D.L., and Earnshaw W.C. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 166 (2004) 179-191
18. Prescott J.E., Osthus R.C., Lee L.A., Lewis B.C., Shim H., Barrett J.F., Guo Q., Hawkins A.L., Griffin C.A., and Dang C.V. A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation. J. Biol. Chem. 276 (2001) 48276-48284
19. Haggerty T.J., Zeller K.I., Osthus R.C., Wonsey D.R., and Dang C.V. A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5313-5318
20. Osthus R.C., Karim B., Prescott J.E., Smith B.D., McDevitt M., Huso D.L., and Dang C.V. The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. Cancer Res. 65 (2005) 5620-5627
21. Huang A., Ho C.S., Ponzielli R., Barsyte-Lovejoy D., Bouffet E., Picard D., Hawkins C.E., and Penn L.Z. Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells. Cancer Res. 65 (2005) 5607-5619
22. Pelengaris S., Khan M., and Evan G. c-MYC: more than just a matter of life and death. Nat. Rev., Cancer 2 (2002) 764-776
23. Dang C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19 (1999) 1-11
24. Santoni-Rugiu E., Falck J., Mailand N., Bartek J., and Lukas J. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol. 20 (2000) 3497-3509
25. Aguda B.D., and Algar C.K. A structural analysis of the qualitative networks regulating the cell cycle and apoptosis. Cell Cycle 2 (2003) 538-544
26. Matsumura I., Tanaka H., and Kanakura Y. E2F1 and c-Myc in cell growth and death. Cell Cycle 2 (2003) 333-338
27. Leone G., Sears R., Huang E., Rempel R., Nuckolls F., Park C.H., Giangrande P., Wu L., Saavedra H.I., Field S.J., Thompson M.A., Yang H., Fujiwara Y., Greenberg M.E., Orkin S., Smith C., and Nevins J.R. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8 (2001) 105-113
28. Blackwell T.K., Kretzner L., Blackwood E.M., Eisenman R.N., and Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science 250 (1990) 1149-1151
29. Eisenman R.N. Deconstructing myc. Genes Dev. 15 (2001) 2023-2030
30. Cole M.D., and McMahon S.B. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18 (1999) 2916-2924
31. Grandori C., and Eisenman R.N. Myc target genes. Trends Biochem. Sci. 22 (1997) 177-181
32. Grandori C., Cowley S.M., James L.P., and Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16 (2000) 653-699
33. Hermeking H. The MYC oncogene as a cancer drug target. Curr. Cancer Drug Targets 3 (2003) 163-175
34. Lutz W., Leon J., and Eilers M. Contributions of Myc to tumorigenesis. Biochim. Biophys. Acta 1602 (2002) 61-71
35. Bartek J., and Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490 (2001) 117-122
36. DeGregori J. The genetics of E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta 1620 (2002) 131-150
37. Slansky J.E., and Farnham P.J. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208 (1996) 1-30
38. Harbour J.W., and Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14 (2000) 2393-2409
39. Lukas J., Petersen B.O., Holm K., Bartek J., and Helin K. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol. 16 (1996) 1047-1057
40. DeGregori J., Leone G., Miron A., Jakoi L., and Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 7245-7250
41. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat. Rev., Mol. Cell Biol. 3 (2002) 11-20
42. Chen K., Ou X.M., Chen G., Choi S.H., and Shih J.C. R1, a novel repressor of the human monoamine oxidase A. J. Biol. Chem. 280 (2005) 11552-11559
43. Amati B., Alevizopoulos K., and Vlach J. Myc and the cell cycle. Front. Biosci. 3 (1998) 250-268
44. Johnson D.G., Schwarz J.K., Cress W.D., and Nevins J.R. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 13 (1993) 349-352
45. Vigo E., Muller H., Prosperini E., Hateboer G., Cartwright P., Moroni M.C., and Helin K. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19 (1999) 6379-6395
46. Obaya A.J., Mateyak M., and Sedivy J.M. Mysterious liaisons: the relationship between c-Myc and the cell cycle. Oncogene 18 (1999) 2934-2941
47. Santoni-Rugiu E., Duro D., Farkas T., Mathiasen I.S., Jaattela M., Bartek J., and Lukas J. E2F activity is essential for survival of Myc-overexpressing human cancer cells. Oncogene 21 (2002) 6498-6509
48. Tanaka H., Matsumura I., Ezoe S., Satoh Y., Sakamaki T., Albanese C., Machii T., Pestell R.G., and Kanakura Y. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. Mol. Cell 9 (2002) 1017-1029
49. Eischen C.M., Packham G., Nip J., Fee B.E., Hiebert S.W., Zambetti G.P., and Cleveland J.L. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene 20 (2001) 6983-6993
50. Perez-Roger I., Solomon D.L., Sewing A., and Land H. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14 (1997) 2373-2381
51. Ohtani K., DeGregori J., and Nevins J.R. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 12146-12150
52. Galaktionov K., Chen X., and Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382 (1996) 511-517
53. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., and Cole M.D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94 (1998) 363-374